Ayurcann Holdings Corp (CSE: AYUR) CEO Igal Sudman joined Steve Darling from Proactive to share details the company has signed an agreement to manufacture products with Bazelet Nehushtan and Bazelet Development and Technologies which is a huge licensed medical cannabis processor in Israel.
Sudman telling Proactive Ayurcann will manufacture and distribute 3 different Bazelet products which will also be introduced to the Canadian marketplace.